AmBisome administration for Candida albicans shunt infections

J Antimicrob Chemother. 2003 Dec;52(6):1048-9. doi: 10.1093/jac/dkg475. Epub 2003 Oct 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Amphotericin B / adverse effects
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / adverse effects
  • Antifungal Agents / therapeutic use*
  • Candidiasis / drug therapy*
  • Candidiasis / microbiology
  • Humans
  • Male
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / microbiology
  • Stroke / complications
  • Stroke / surgery
  • Ventriculoperitoneal Shunt*

Substances

  • Antifungal Agents
  • liposomal amphotericin B
  • Amphotericin B